Tolerability is often measured using patient-reported outcomes, clinical assessments, and biomarkers. Common scales include the Common Terminology Criteria for Adverse Events (CTCAE) and the Eastern Cooperative Oncology Group (ECOG) performance status. These tools help clinicians gauge the severity of side effects and the impact on the patient's daily life.
